Mercados españoles cerrados en 6 hrs 15 min

Danaher Corporation (DHR)

NYSE - NYSE Precio demorado. Divisa en USD
Añadir a la lista de favoritos
236,08+0,57 (+0,24%)
Al cierre: 04:00PM EDT
239,85 +3,77 (+1,60%)
Antes de la apertura: 04:58AM EDT

Danaher Corporation

2200 Pennsylvania Avenue, North West
Suite 800 West
Washington, DC 20037-1701
United States
202 828 0850
https://www.danaher.com

Sector(es)Healthcare
SectorDiagnostics & Research
Empleados a tiempo completo61.000

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Steven M. RalesCo-Founder & ChairmanN/AN/A1951
Mr. Rainer M. BlairPresident, CEO & Director5,33MN/A1964
Mr. Mitchell P. RalesCo-Founder & DirectorN/AN/A1957
Mr. Matthew R. McGrewCFO & Executive VP2,56MN/A1972
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior VP & Chief Science Officer2,09MN/A1962
Ms. Georgeann F. CoucharaSenior Vice President of Human Resources1,66MN/A1977
Mr. Joakim WeidemanisExecutive Vice President2,76M6,5M1969
Mr. Christopher M. BoudaVP & Chief Accounting OfficerN/AN/AN/A
Mr. John BedfordVice President of Investor RelationsN/AN/AN/A
Mr. Brian W. EllisSenior VP, General Counsel & Chief Compliance Officer1,93MN/A1967
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Gobierno corporativo

El ISS Governance QualityScore de Danaher Corporation, a día 1 de abril de 2024, es 7. Las puntuaciones base son Auditoría: 9; Tablero: 10; Derechos de los accionistas: 2; Compensación: 2.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.